Piotr Sicinski

18PUBLICATIONS
147CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|Apr 02, 2026
HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.

Marie-Anne Goyette, Christopher Graser, Marco Seehawer

|Mar 18, 2026
Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Anne Fassl, Miriam Palacios Espinoza, Deborah Butter

|Oct 22, 2025
Transcriptional cyclin-dependent kinases Cdk8 and Cdk19 are required for normal macrophage differentiation.

Aleksandra Kolodziejczyk, Samantha Liu, Fabian Strobel

|Jul 15, 2025
Targeting Transcriptional Cyclin-Dependent Kinases in Cancer.

Aleksandra Kolodziejczyk, Piotr Sicinski

|Feb 23, 2024
PC4: A new regulator of cyclin D1 transcript levels.

Anne Fassl, Piotr Sicinski

Pageof 3

Frequent Collaborators

6 joint publications

Kornelia Polyak

5 joint publications

Chen Chu

5 joint publications

Aleksandra Kolodziejczyk

4 joint publications

Anne Fassl